Back
Alnylam Pharmaceuticals Vs. Summit Midstream Industry Stock Comparison
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$270.19
Seasonality Move:
25.91%
Sell
37
SMC
Summit Midstream
Last Price:
$29.00
Seasonality Move:
5.89%
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $251.15. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Summit Midstream (SMC)
is a Sell
Is Summit Midstream a Buy, Sell or Hold?
-
The current Summit Midstream [SMC] share price is $28.34. The Score for SMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $251.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
SMC Stock Price Chart
What is Summit Midstream's stock price today?
-
The Summit Midstream share price today is $28.34The current trend is relatively stagnant and SMC is experiencing slight buying pressure.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.09 | Buy |
| Relative Strength Index (14 RSI): | 48.55 | Sell |
| Chaikin Money Flow: | -547536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (231.81 - 261.09) | Buy |
| Bollinger Bands (100): | (237.33 - 268.25) | Sell |
SMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.27 | Sell |
| Relative Strength Index (14 RSI): | 44.53 | Sell |
| Chaikin Money Flow: | 7541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.11 - 29.13) | Buy |
| Bollinger Bands (100): | (30.8 - 42.12) | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 263.4 | Sell |
| 20-day SMA: | 249.93 | Buy |
| 50-day SMA: | 251.22 | Sell |
| 200-day SMA: | 259.09 | Sell |
| 8-day EMA: | 260.23 | Sell |
| 20-day EMA: | 255.26 | Sell |
| 50-day EMA: | 253.2 | Sell |
| 200-day EMA: | 245.77 | Buy |
SMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.68 | Buy |
| 20-day SMA: | 28.17 | Buy |
| 50-day SMA: | 32.81 | Sell |
| 200-day SMA: | 36.3 | Sell |
| 8-day EMA: | 28 | Buy |
| 20-day EMA: | 28.78 | Sell |
| 50-day EMA: | 31.87 | Sell |
| 200-day EMA: | 34.26 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
Summit Midstream Earnings Growth & SMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Midstream Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||